Neutral
How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates
Praxis Precision Medicines (PRAX) has achieved two significant FDA milestones: Priority Review for relutrigine in pediatric epilepsy, with a PDUFA dat...